{"filing":{"accession_number":"0001628280-26-052598","cik":"0001756655","ticker":"ARDT","company_name":"Ardent Health, Inc.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"ardt-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1756655/000162828026052598/ardt-20260804.htm"},"events":[{"id":24245,"run_id":21953,"accession_number":"0001628280-26-052598","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release for Q2 2026 ended June 30, 2026, filed on August 4, 2026. The press release discloses total revenue of $1.62 billion, net income of $17 million, adjusted EBITDA of $115 million, and reaffirms full-year 2026 guidance. The filing is structured as Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":24733,"accession_number":"0001628280-26-052598","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026, filed on August 4, 2026. The press release discloses total revenue of $1.62 billion, net income of $17 million, adjusted EBITDA of $115 million, and reaffirms full-year 2026 guidance. The filing is structured as Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:15:10.372657+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24733,"accession_number":"0001628280-26-052598","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026, filed on August 4, 2026. The press release discloses total revenue of $1.62 billion, net income of $17 million, adjusted EBITDA of $115 million, and reaffirms full-year 2026 guidance. The filing is structured as Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:15:10.372657+00:00","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-08-04"}]}